Argentina Neurological Disorder Drugs Market (2025-2031) | Segmentation, Forecast, Industry, Size & Revenue, Growth, Value, Outlook, Analysis, Competitive Landscape, Share, Companies, Trends

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Argentina Country Macro Economic Indicators

3.2 Argentina Neurological Disorder Drugs Market Revenues & Volume, 2021 & 2031F

3.3 Argentina Neurological Disorder Drugs Market - Industry Life Cycle

3.4 Argentina Neurological Disorder Drugs Market - Porter's Five Forces

3.5 Argentina Neurological Disorder Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F

3.6 Argentina Neurological Disorder Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.7 Argentina Neurological Disorder Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.8 Argentina Neurological Disorder Drugs Market Revenues & Volume Share, By End-Users, 2021 & 2031F

3.9 Argentina Neurological Disorder Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of neurological disorders in Argentina

4.2.2 Growing awareness and diagnosis of neurological disorders

4.2.3 Advancements in research and development of neurological disorder drugs

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for drug approval

4.3.2 High cost associated with neurological disorder drugs

4.3.3 Limited access to specialized healthcare services in certain regions of Argentina

6.1 Argentina Neurological Disorder Drugs Market, By Indication

6.1.1 Overview and Analysis

6.1.2 Argentina Neurological Disorder Drugs Market Revenues & Volume, By Indication, 2021- 2031F

6.1.3 Argentina Neurological Disorder Drugs Market Revenues & Volume, By Epilepsy, 2021- 2031F

6.1.4 Argentina Neurological Disorder Drugs Market Revenues & Volume, By Alzheimers Disease, 2021- 2031F

6.1.5 Argentina Neurological Disorder Drugs Market Revenues & Volume, By Parkinsons Disease, 2021- 2031F

6.1.6 Argentina Neurological Disorder Drugs Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F

6.1.7 Argentina Neurological Disorder Drugs Market Revenues & Volume, By Cerebrovascular Disease, 2021- 2031F

6.1.8 Argentina Neurological Disorder Drugs Market Revenues & Volume, By Others, 2021- 2031F

6.2 Argentina Neurological Disorder Drugs Market, By Drug Class

6.2.1 Overview and Analysis

6.2.2 Argentina Neurological Disorder Drugs Market Revenues & Volume, By Cholinesterase Inhibitors, 2021- 2031F

6.2.3 Argentina Neurological Disorder Drugs Market Revenues & Volume, By NMDA Receptor Antagonists, 2021- 2031F

6.2.4 Argentina Neurological Disorder Drugs Market Revenues & Volume, By Antiepileptic, 2021- 2031F

6.2.5 Argentina Neurological Disorder Drugs Market Revenues & Volume, By Antipsychotic and Antidepressant, 2021- 2031F

6.2.6 Argentina Neurological Disorder Drugs Market Revenues & Volume, By Others, 2021- 2031F

6.3 Argentina Neurological Disorder Drugs Market, By Route of Administration

6.3.1 Overview and Analysis

6.3.2 Argentina Neurological Disorder Drugs Market Revenues & Volume, By Oral, 2021- 2031F

6.3.3 Argentina Neurological Disorder Drugs Market Revenues & Volume, By Parenteral, 2021- 2031F

6.3.4 Argentina Neurological Disorder Drugs Market Revenues & Volume, By Others, 2021- 2031F

6.4 Argentina Neurological Disorder Drugs Market, By End-Users

6.4.1 Overview and Analysis

6.4.2 Argentina Neurological Disorder Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F

6.4.3 Argentina Neurological Disorder Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F

6.4.4 Argentina Neurological Disorder Drugs Market Revenues & Volume, By Homecare, 2021- 2031F

6.4.5 Argentina Neurological Disorder Drugs Market Revenues & Volume, By Others, 2021- 2031F

6.5 Argentina Neurological Disorder Drugs Market, By Distribution Channel

6.5.1 Overview and Analysis

6.5.2 Argentina Neurological Disorder Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.5.3 Argentina Neurological Disorder Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

6.5.4 Argentina Neurological Disorder Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F

6.5.5 Argentina Neurological Disorder Drugs Market Revenues & Volume, By Others, 2021- 2031F

7.1 Argentina Neurological Disorder Drugs Market Export to Major Countries

7.2 Argentina Neurological Disorder Drugs Market Imports from Major Countries

8.1 Patient adherence rate to prescribed neurological disorder drugs

8.2 Number of clinical trials for new neurological disorder drugs in Argentina

8.3 Percentage of healthcare professionals trained in neurological disorder treatment and management

9.1 Argentina Neurological Disorder Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F

9.2 Argentina Neurological Disorder Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.3 Argentina Neurological Disorder Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.4 Argentina Neurological Disorder Drugs Market Opportunity Assessment, By End-Users, 2021 & 2031F

9.5 Argentina Neurological Disorder Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10.1 Argentina Neurological Disorder Drugs Market Revenue Share, By Companies, 2024

10.2 Argentina Neurological Disorder Drugs Market Competitive Benchmarking, By Operating and Technical Parameters